Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyophilized FMT for Recurrent C. Difficile Infection
NCT03834038Completed
- Sponsor
- Island Health
- Start
- Oct 2015
- Primary completion
- Mar 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label, single-arm trial of Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile infection (CDI), sponsored by Island Health. Primary endpoint: No Recurrence of CDI-related Diarrhea at 13 Weeks From Last LYO-FMT. Started Oct 2015; status: completed.
02
Drugs
Lyophilized Fecal Microbiota Transplantation
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT03834038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03834038.